Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector. Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR). Nate & Jason spotlight the First Trust NYSE Arca Biotechnology Index Fund (FBT).
No transcript available.
POWERED BY BLUBRRY
